Author Tomic, Davorka
-
2020 | Journal Article |
Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis
Reinert, M.-C. ; Benkert, P.; Wuerfel, J.; Michalak, Z.; Ruberte, E.; Barro, C. & Huppke, P. et al. (2020)
Neurology - Neuroimmunology Neuroinflammation, 7(4) pp. e749. DOI: https://doi.org/10.1212/NXI.0000000000000749
Details DOI
-
2023 | Conference Paper
Efficacy and Safety of the Bruton’s Tyrosine Kinase Inhibitor Evobrutinib for Relapsing Multiple Sclerosis Over 3.5 Years of Treatment: An Ongoing Phase II Open-Label Extension (S16.008)
Montalban, X.; Wolinsky, J. S.; Arnold, D. L.; Weber, M. S.; Piasecka-Stryczynska, K.; Tomic, D. & Seitzinger, A. et al. (2023)
p. 3752. 2023 Annual Meeting Abstracts
Lippincott Williams & Wilkins. DOI: https://doi.org/10.1212/WNL.0000000000203500
Details DOI
-
2024 | Journal Article
Efficacy and safety results after >3.5 years of treatment with the Bruton’s tyrosine kinase inhibitor evobrutinib in relapsing multiple sclerosis: Long-term follow-up of a Phase II randomised clinical trial with a cerebrospinal fluid sub-study
Montalban, X.; Piasecka-Stryczynska, K.; Kuhle, J.; Benkert, P.; Arnold, D. L; Weber, M. S & Seitzinger, A. et al. (2024)
Multiple Sclerosis Journal, art. 13524585241234783. DOI: https://doi.org/10.1177/13524585241234783
Details DOI